Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
16 p, 3.8 MB Genetic and phenotypic attributes of splenic marginal zone lymphoma / Bonfiglio, Ferdinando (Institute of Oncology Research, Bellinzona, Switzerland) ; Bruscaggin, Alessio (Institute of Oncology Research, Bellinzona, Switzerland) ; Guidetti, Francesca (Institute of Oncology Research, Bellinzona, Switzerland) ; Terzi di Bergamo, Lodovico (Institute of Oncology Research, Bellinzona, Switzerland) ; Faderl, Martin (Institute of Oncology Research, Bellinzona, Switzerland) ; Spina, Valeria (Institute of Oncology Research, Bellinzona, Switzerland) ; Condoluci, Adalgisa (Institute of Oncology Research, Bellinzona, Switzerland) ; Bonomini, Luisella (International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) ; Forestieri, Gabriela (Institute of Oncology Research, Bellinzona, Switzerland) ; Koch, Ricardo (Institute of Oncology Research, Bellinzona, Switzerland) ; Piffaretti, Deborah (Institute of Oncology Research, Bellinzona, Switzerland) ; Pini, Katia (Institute of Oncology Research, Bellinzona, Switzerland) ; Pirosa, Maria Cristina (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Cittone, Micol Giulia (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Arribas, Alberto (Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland) ; Lucioni, Marco (Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy) ; Ghilardi, Guido (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.) ; Wu, Wei (Institute of Oncology Research, Bellinzona, Switzerland) ; Arcaini, Luca (University of Pavia, Pavia, Italy.) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bastidas-Mora, Gabriela (Hospital Clínic i Provincial de Barcelona) ; Bea, Sílvia (Hospital Clínic i Provincial de Barcelona) ; Boldorini, Renzo (University of Eastern Piedmont, Novara, Italy) ; Broccoli, Alessandro (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.) ; Buehler, Marco Matteo (University Hospital Zurich, Switzerland) ; Canzonieri, Vincenzo (Pathology Unit, CRO Aviano National Cancer Institute, Aviano, Italy) ; Cascione, Luciano (Institute of Oncology Research, Bellinzona, Switzerland) ; Ceriani, Luca (Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland) ; Cogliatti, Sergio (Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland) ; Corradini, Paolo (Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy) ; Derenzini, Enrico (European Institute of Oncology (IEO) IRCCS, Milan, Italy) ; Devizzi, Liliana (Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy) ; Dietrich, Sascha (University Hospital Heidelberg, Germany) ; Elia, Angela Rita (Institute of Oncology Research, Bellinzona, Switzerland) ; Facchetti, Fabio (Pathology Unit, Spedali Civili, Brescia, Italy) ; Gaidano, Gianluca (University of Eastern Piedmont, Novara, Italy) ; Garcia, Juan Fernando (MD Anderson Cancer Center, Madrid) ; Gerber, Bernhard (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Ghia, Paolo (IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy) ; Gomes da Silva, Maria (Instituto Português de Oncologia de Lisboa, Portugal) ; Gritti, Giuseppe (Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy) ; Guidetti, Anna (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy) ; Hitz, Felicitas (Kantonsspital St Gallen, St Gallen, Switzerland) ; Inghirami, Giorgio (Weill Cornell Medical College, New York) ; Ladetto, Marco (Azienda Ospedaliera SS Antonio e Biagio, Alessandria, Italy) ; Lopez-Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Lucchini, Elisa (Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy) ; Maiorana, Antonino (Universitá degli Studi di Modena e Reggio Emilia, Modena, Italy) ; Marasca, Roberto (University of Modena and Reggio Emilia, Modena, Italy) ; Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ; Meignin, Veronique (Saint Louis Hospital, Paris, France) ; Merli, Michele (University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy) ; Moccia, Alden (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Mollejo, Manuela (Hospital Virgen de la Salud (Toledo)) ; Montalban, Carlos (MD Anderson Cancer Center, Madrid) ; Novak, Urban (University of Bern, Bern, Switzerland) ; Oscier, David Graham (University Hospitals Dorset, Bournemouth, United Kingdom) ; Passamonti, Francesco (University of Insubria) ; Piazza, Francesco (Ospedale Universitario di Padova, Italy) ; Pizzolitto, Stefano (General Hospital S Maria della Misericordia, Udine, Italy) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy) ; Sabattini, Elena (University of Bologna, Italy) ; Salles, Gilles (Université de Lyon, France) ; Santambrogio, Elisa (Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy) ; Scarfò, Lydia (IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy) ; Stathis, Anastasios (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Stüssi, Georg (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Geyer, Julia T. (Weill Cornell Medical College, New York) ; Tapia, G. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tarella, Corrado (European Institute of Oncology (IEO) IRCCS, Milan, Italy) ; Thieblemont, Catherine (Université de Paris, France) ; Tousseyn, Thomas (University Hospitals Leuven, Belgium) ; Tucci, Alessandra (Spedali Civili, Brescia, Italy.) ; Vanini, Giorgio (University of Bern, Switzerland) ; Visco, Carlo (University of Verona, Italy) ; Vitolo, Umberto (Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy) ; Walewska, Renata (University Hospitals Dorset, Bournemouth, United Kingdom) ; Zaja, Francesco (Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy) ; Zenz, Thorsten (University Hospital Zurich, Switzerland) ; Zinzani, Pier Luigi (Università di Bologna, Italy) ; Khiabanian, Hossein (Rutgers University, New Brunswick) ; Calcinotto, Arianna (Institute of Oncology Research, Bellinzona, Switzerland) ; Bertoni, Francesco (Institute of Oncology Research, Bellinzona, Switzerland) ; Bhagat, Govind (Columbia University, New York, USA) ; Campo, Elias (Hospital Clínic i Provincial de Barcelona) ; de Leval, Laurence (Institut Universitaire de Pathologie, Lausanne, Switzerland) ; Dirnhofer, Stefan (University Hospital Basel (Basilea, Suïssa)) ; Pileri, Stefano A. (European Institute of Oncology IRCCS, Milan, Italy) ; Piris, Miguel Angel (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid) ; Traverse-Glehen, Alexandra (Centre Hospitalier Lyon Sud, Lyon, France) ; Tzankov, Alexander (University Hospital Basel (Basilea, Suïssa)) ; Paulli, Marco (Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Italy) ; Ponzoni, Maurilio (Ateneo Vita-Salute San Raffaele University and Pathology Unit San Raffaele Scientific Institute, Milan, Italy) ; Mazzucchelli, Luca (antonal Institute of Pathology, Locarno, Switzerland) ; Cavalli, Franco (Institute of Oncology Research, Bellinzona, Switzerland; and.) ; Zucca, Emanuele (International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) ; Rossi, Davide (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Universitat Autònoma de Barcelona
Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity. The clinical course is variable, multiple genes are mutated with no unifying mechanism, and essential regulatory pathways and surrounding microenvironments are diverse. [...]
2022 - 10.1182/blood.2021012386
Blood, Vol. 139 Núm. 5 (february 2022) , p. 732-747  
2.
14 p, 1.9 MB Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma / Frontzek, Fabian (University Hospital of Münster (Alemanya)) ; Staiger, Annette M. (Robert Bosch Hospital) ; Zapukhlyak, Myroslav (University Hospital of Münster (Alemanya)) ; Xu, Wendan (University Hospital of Münster (Alemanya)) ; Bonzheim, Irina (University Hospital of Tübingen (Alemanya)) ; Borgmann, Vanessa (University Hospital of Tübingen (Alemanya)) ; Sander, Philip (University Hospital of Tübingen (Alemanya)) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Heming, Jan-Niklas (University Hospital of Münster (Alemanya)) ; Berning, Philipp (University Hospital of Münster (Alemanya)) ; Wullenkord, Ramona (University Hospital of Münster (Alemanya)) ; Erdmann, Tabea (University Hospital of Münster (Alemanya)) ; Lutz, Mathias (University Hospital of Münster (Alemanya)) ; Veratti, Pia (University Hospital Freiburg) ; Ehrenfeld, Sophia (University of Freiburg) ; Wienand, Kirsty (University Medical Center Göttingen) ; Horn, Heike (Robert Bosch Hospital) ; Goodlad, John R. (Queen Elizabeth University Hospital) ; Wilson, Matthew R. (Beatson West of Scotland Cancer Centre (Glasgow, Regne Unit)) ; Anagnostopoulos, Ioannis (Charité - Universitätsmedizin Berlin) ; Lamping, Mario (Charité - Universitätsmedizin Berlin) ; González Barca, Eva (Universitat de Barcelona) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Salar, Antonio (Hospital del Mar (Barcelona, Catalunya)) ; Castellvi, Josep (Hospital Universitari Vall d'Hebron) ; Abrisqueta, Pau (Hospital Universitari Vall d'Hebron) ; Menarguez, Javier (Hospital General Universitario Gregorio Marañón) ; Aldámiz-Echevarría, T (Hospital General Universitario Gregorio Marañón) ; Richter, Julia (Christian-Albrechts-University) ; Klapper, Wolfram (Christian-Albrechts-University) ; Tzankov, Alexander (University Hospital Basel (Basilea, Suïssa)) ; Dirnhofer, Stefan (University Hospital Basel (Basilea, Suïssa)) ; Rosenwald, Andreas (University of Würzburg) ; Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Lenz, Peter (Department of Physics. University of Marburg) ; Miething, C. (German Cancer Research Center) ; Hartmann, Wolfgang (University Hospital of Münster (Alemanya)) ; Chapuy, Björn (University Medical Center Göttingen) ; Fend, Falko (University Hospital of Tübingen (Alemanya)) ; Ott, Gustav (Department of Clinical Pathology. Robert Bosch Hospital) ; Navarro, José-Tomás (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Grau, Michael (University Hospital of Münster (Alemanya)) ; Lenz, Georg (University Hospital of Münster (Alemanya)) ; Universitat Autònoma de Barcelona
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype frequently associated with immunosuppression. Clinically, patients with PBL are characterized by poor outcome. The current understanding of the molecular pathogenesis is limited. [...]
2021 - 10.1038/s41467-021-25405-w
Nature communications, Vol. 12 Núm. 1 (january 2021) , p. 5183  

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.